Amedisys Q3 Adj. EPS $0.98 Misses $1.08 Estimate, Sales $556.20M Miss $561.27M Estimate
Portfolio Pulse from Benzinga Newsdesk
Amedisys (NASDAQ:AMED) reported Q3 earnings of $0.98 per share, missing the analyst consensus estimate of $1.08 by 9.26%. This is a 14.78% decrease from the same period last year. The company also reported quarterly sales of $556.20 million, missing the analyst consensus estimate of $561.27 million by 0.90%. This is a 0.32% decrease from the same period last year.
October 24, 2023 | 8:44 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amedisys reported lower than expected Q3 earnings and sales, which could negatively impact its stock price in the short term.
Amedisys reported lower than expected earnings and sales for Q3. This underperformance could lead to a decrease in investor confidence and a potential drop in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100